Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

LexaGene develops test for deadly mosquito-borne Eastern Equine Encephalitis virus

Proactive Investors Tuesday, 17 September 2019
LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) announced Tuesday the development of a test to detect the deadly Eastern Equine Encephalitis (EEE) virus on its LX technology platform. The EEE virus can be transmitted through the bite of an infected mosquito, and has recently caused fatal infections in Michigan, Massachusetts and Rhode Island, the company said in a statement.  The virus is particularly serious for both children and the elderly and can lead to death in approximately 30% of infected individuals. READ: LexaGene's LX Analyzer to be tested in one of the largest hemp-cannabis labs in Massachusetts Northeastern states typically test in excess of 15,000 samples per year for EEE. This year, Massachusetts state testing labs alone have processed thousands of samples of which more than 400 mosquito samples were found to be positive for the presence of EEE virus. Previously, LexaGene’s technology was only able to detect DNA-based pathogens.  Now the company said it has modified the analyzer to also detect pathogens that have RNA-based genomes. Examples of pathogens that have RNA-based genomes include EEE and other mosquito-borne viruses such as West Nile, Chikungunya and Zika viruses, as well as other deadly pathogens such as influenza and Ebola.  Another benefit of the LX Analyzer, the Massachusetts-based company said, is its ability to screen for multiple pathogens at once, which is critical for carrying out successful screening programs of mosquito populations for vector-borne viruses. “Testing mosquitoes for the presence of human pathogens is an integral part of surveillance activities. We have now used our LX Analyzer to successfully amplify the EEE virus sequence from mosquito RNA samples spiked with EEE RNA,” said CEO Dr Jack Regan.  “Our technology is automated and designed to reduce hands-on processing time, which is a benefit to molecular testing laboratories. We are pursuing this work to demonstrate that LexaGene’s technology can be part of the solution for bolstering surveillance efforts intended to determine when mosquito abatement programs should be started to minimize the number of human cases.” LexaGene said it welcomes members of the public, including businesses and testing laboratories, to send mosquitoes to their laboratory for testing. Contact the author: [email protected] Follow him on Twitter @PatrickMGraham
0
shares
ShareTweetSavePostSend
 
Credit: Wibbitz Studio - Published < > Embed
News video: Over $170,000 Donated to Child With Rare EEE Disease

Over $170,000 Donated to Child With Rare EEE Disease 01:19

Over $170,000 Donated to Child With Rare EEE Disease Five-year-old Sophia Garabedian was diagnosed with Eastern equine encephalitis earlier this month. The virus, which is spread by mosquitoes, causes potentially fatal brain swelling. According to the Centers for Disease Control and Prevention,...

You Might Like


Recent related videos from verified sources

Strangers Raise $190,000 for 5-Year-Old Diagnosed With EEE [Video]Strangers Raise $190,000 for 5-Year-Old Diagnosed With EEE

A 5-year-old girl has beaten Eastern Equine Encephalitis, otherwise known as EEE thanks to the kindness of strangers.

Credit: Sharecare - Affiliate     Duration: 01:10Published

5th Person in West Michigan Dies from EEE [Video]5th Person in West Michigan Dies from EEE

A fifth West Michigan resident has died from Eastern equine encephalitis.

Credit: WXMI     Duration: 00:40Published


Recent related news from verified sources

Deadly Eastern equine encephalitis virus found in mosquito pool in Windsor, Ont.

The rare but deadly mosquito-borne virus Eastern equine encephalitis (EEE) has been found in Windsor, Ont., according to the Windsor-Essex County Health Unit.
CBC.ca

Imugene plans to begin Phase 1 oncolytic virus technology clinical trials in 2020

Imugene Ltd (ASX:IMU) is advancing its preliminary clinical development plan (CDP) for the proposed exclusive license of the patents covering the CF33 oncolytic...
Proactive Investors

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.